Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

Predictors of immunity after hepatitis A vaccination in HIV-infected persons.

Overton ET, Nurutdinova D, Sungkanuparph S, Seyfried W, Groger RK, Powderly WG.

J Viral Hepat. 2007 Mar;14(3):189-93.

PMID:
17305885
2.

Response to hepatitis A vaccine in HIV-positive patients.

Weissman S, Feucht C, Moore BA.

J Viral Hepat. 2006 Feb;13(2):81-6.

PMID:
16436125
3.

[Efficacy of vaccination against hepatitis A in HIV infected adults from Lodz region--preliminary report].

Jabłonowska E, Kuydowicz J, Małolepsza E.

Przegl Epidemiol. 2008;62(3):605-12. Polish.

PMID:
19108525
4.

Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?

Jimenez HR, Hallit RR, Debari VA, Slim J.

Vaccine. 2013 Feb 18;31(9):1328-33. doi: 10.1016/j.vaccine.2012.12.045.

PMID:
23277097
5.

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.

Weinberg A, Gona P, Nachman SA, Defechereux P, Yogev R, Hughes W, Wara D, Spector SA, Read J, Elgie C, Cooper M, Dankner W; Pediatric AIDS Clinical Trials Group 1008 Team..

J Infect Dis. 2006 Jan 15;193(2):302-11.

6.

Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents.

Siberry GK, Coller RJ, Henkle E, Kiefner C, Joyner M, Rogers J, Chang J, Hutton N.

Pediatr Infect Dis J. 2008 May;27(5):465-8. doi: 10.1097/INF.0b013e31816454a3.

PMID:
18382387
7.

Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons.

Overton ET, Sungkanuparph S, Powderly WG, Seyfried W, Groger RK, Aberg JA.

Clin Infect Dis. 2005 Oct 1;41(7):1045-8.

8.

Durability of response to vaccination against viral hepatitis A in HIV-infected patients: a 5-year observation.

Jabłonowska E, Kuydowicz J.

Int J STD AIDS. 2014 Sep;25(10):745-50. doi: 10.1177/0956462413518902.

PMID:
24452731
9.

Immune response to hepatitis A vaccination in HIV-infected men in Greece.

Kourkounti S, Mavrianou N, Paparizos VA, Kyriakis K, Hatzivassiliou M, Kordosis T, Katsambas A.

Int J STD AIDS. 2012 Jul;23(7):464-7. doi: 10.1258/ijsa.2011.011297.

PMID:
22843998
10.

Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study.

Launay O, Grabar S, Gordien E, Desaint C, Jegou D, Abad S, Girard PM, Bélarbi L, Guérin C, Dimet J, Williams V, Krivine A, Salmon D, Lortholary O, Rey D; HEPAVAC Study Group1..

J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):272-5. doi: 10.1097/QAI.0b013e318183a9c0.

PMID:
18845961
11.

Adherence to hepatitis A virus vaccination in HIV-infected men who have sex with men.

Kourkounti S, Paparizos V, Leuow K, Paparizou E, Antoniou C.

Int J STD AIDS. 2015 Oct;26(12):852-6. doi: 10.1177/0956462414560274.

PMID:
25411352
12.

Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.

Tseng YT, Chang SY, Liu WC, Sun HY, Wu CH, Wu PY, Lu CL, Hung CC, Chang SC.

Hepatology. 2013 May;57(5):1734-41. doi: 10.1002/hep.26210.

PMID:
23258666
13.

[Efficacy of vaccination against hepatitis B in adult with HIV infection].

Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T.

Przegl Epidemiol. 2007;61(2):339-47. Polish.

PMID:
17956052
14.

Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.

Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD; HIV Outpatient Study (HOPS) Investigators..

Clin Infect Dis. 2004 May 15;38(10):1478-84.

15.

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.

Laurence JC.

Am J Med. 2005 Oct;118 Suppl 10A:75S-83S. Review.

PMID:
16271546
16.

Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.

Bailey CL, Smith V, Sands M.

Int J Infect Dis. 2008 Nov;12(6):e77-83. doi: 10.1016/j.ijid.2008.05.1226.

17.

Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.

Günthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, Christopherson C, Hwang J, Haubrich R, Havlir D, Richman DD.

J Infect Dis. 2000 Feb;181(2):522-31.

18.

Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.

Wallace MR, Brandt CJ, Earhart KC, Kuter BJ, Grosso AD, Lakkis H, Tasker SA.

Clin Infect Dis. 2004 Oct 15;39(8):1207-13.

19.

Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland.

Crisinel PA, Posfay-Barbe KM, Aebi C, Cheseaux JJ, Kahlert C, Rudin C, Nadal D, Siegrist CA; Swiss Mother and Child HIV Cohort Study of Switzerland..

Clin Vaccine Immunol. 2012 Nov;19(11):1751-7. doi: 10.1128/CVI.00264-12.

20.
Items per page

Supplemental Content

Support Center